Potential hazard with syringe infusion pump

Anaesthesia

Volumn 56, Issue 9, 2001, Pages 906-924

  Kannan, S ^a  

^a CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

REMIFENTANIL; KETOPROFEN; KETOROLAC; PROCHLORPERAZINE;

BIOMEDICAL TECHNOLOGY ASSESSMENT; BRADYCARDIA; DOSE RESPONSE; DRUG DELIVERY SYSTEM; DRUG POTENCY; FLOW RATE; HAZARD; HUMAN; HYPOTENSION; INSULIN PUMP; LETTER; SYRINGE; ANALGESIA; CLINICAL TRIAL; DRUG ANTAGONISM; DRUG EFFECT; DRUG FORMULATION; DRUG INCOMPATIBILITY; INTRAOPERATIVE PERIOD; PAIN; PH MEASUREMENT; PHYSICAL CHEMISTRY; PRECIPITATION; RETINA SURGERY; SURGICAL TECHNIQUE; VITRECTOMY; VOMITING;

EID: 0034852352     PISSN: 00032409     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2044.2001.02230-13.x     Document Type: Letter

References (3)

1. Design flaw can covert commercially available continuous syringe pumps to intermittent bolus injectors
2. A hazard occurring with a syringe driver pump